NeuroGenetic Pharmaceuticals (United States)

NeuroGenetic Pharmaceuticals (United States)

Open Access statistics for NeuroGenetic Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023.

Open Access statistics for NeuroGenetic Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

73%


Total
Publications

55


Total Open
Publications

40


Total
Citations

1.9K


Open Access
Percentage

73%


Total
Publications

55


Total Open
Publications

40


Total
Citations

1.9K

Website

download

Breakdown

17% 49% 7% 27%

Publisher Open

17%

Both

49%

Other Platform Open

7%

Closed

27%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

36%OA Journal

OA Journal 36%

13

Hybrid 47%

17

No Guarantees 17%

6

Other Platform Open

Domain 97%

30

Institution 10%

3

Preprint 3%

1

Other Internet 3%

1

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
30
Europe PMC
Domain
9
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - Aix-Marseille Université
Institution
2
wustl.edu OAI-PMH Repository
Institution
1
Washington University School of Medicine - Digital Commons@Becker
Institution
1
University of Duisburg-Essen - DuEPublico
Institution
1
University of California - eScholarship University of California
Institution
1
Research Square
Preprint
1
Newcastle Univesity - Newcastle University ePrints
Institution
1
1 / 2

Data updated 8 December 2024

Share

Share

Share